Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection

Infection. 2019 Jun;47(3):497-500. doi: 10.1007/s15010-019-01274-w. Epub 2019 Feb 7.

Abstract

Introduction: A woman infected by carbapenem-resistant Klebsiella pneumoniae is reported in this study.

Case report: Tigecycline and meropenem combination was used, and indeed, in vitro checkerboard synergy test confirmed the antagonism between the two antibiotics. Thus, meropenem was ceased and single high-dose tigecycline was successful against the infection. Subsequent experiments showed that the isolates of the KPC-2-producing K. pneumoniae ST11 clone caused the infection.

Conclusion: Therefore, tigecycline and meropenem combination should be used with caution.

Keywords: Antagonistic effect; Carbapenem-resistance; KPC-2-producing Klebsiella pneumoniae; Meropenem; Tigecycline.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents*
  • China
  • Drug Resistance, Bacterial / genetics
  • Female
  • Gene Expression Regulation, Bacterial
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Meropenem / antagonists & inhibitors*
  • Microbial Sensitivity Tests
  • Tigecycline / antagonists & inhibitors*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • beta-lactamase KPC-1
  • beta-Lactamases
  • Meropenem